Digital health

DATAcc by DiMe Launches Digital Strategy for Standardized Measurement of Physical Activity

Retrieved on: 
Tuesday, February 13, 2024
Analog Devices, Bangladesh Technical Education Board, Digital health, Merck, National Institutes of Health, Exercise, Health, Defense Innovation Unit, COPD, Patient, Dime, Research, Partnership, Medical imaging

BOSTON, Feb. 13, 2024 /PRNewswire/ -- Today, the Digital Health Measurement Collaborative Community (DATAcc) by the Digital Medicine Society (DiMe) released a core set of digital measures for physical activity, providing a roadmap for leveraging digital tools to measure the '6th vital sign.' Researchers and healthcare professionals can now better assess and address the impact of exercise on an individual's well-being. The measures were developed in partnership with industry leaders following a cross-disciplinary, evidence-based research project. New resources – including ontologies, a decision tool, and illustrative scenarios – provide specific support to clinical researchers, healthcare providers and decision-makers, and digital health technology developers to effectively implement these new core measures.

Key Points: 
  • Core measures and other resources are now available to support an industry standard for digitally measured physical activity, increasingly recognized as the '6th vital sign'
    BOSTON, Feb. 13, 2024 /PRNewswire/ -- Today, the Digital Health Measurement Collaborative Community ( DATAcc ) by the Digital Medicine Society ( DiMe ) released a core set of digital measures for physical activity , providing a roadmap for leveraging digital tools to measure the '6th vital sign.'
  • The importance of physical activity to health has long been recognized, and technology exists today to seamlessly measure it in the broad population.
  • "This new core set of digital measures for physical activity will advance the industry by reducing duplicative efforts and speeding the path to discoveries that will benefit the patients we aim to serve," said Jennifer Goldsack, CEO of DiMe.
  • Building off this momentum and extending its portfolio of digital measures work , DATAcc is now convening a project team to build the business case for digital endpoints.

Gigantic Playground Welcomes Eric Soto as Partner & Senior Vice-President of Themed-Entertainment

Retrieved on: 
Monday, February 12, 2024
Technology, Entertainment, Theme Parks, Software, General Entertainment, Other Travel, Destinations, Travel, Cruise, Digital health, Senior, Multimedia, AI, Universal Pictures, Internet of things, Work, Growth, Commerce, Partner, Heart, Imagination, Smart products, Partnership

Today, Gigantic Playground, a leading connected experience agency, proudly announces the strategic appointment of Eric Soto as Partner & Senior Vice-President for Themed-Entertainment.

Key Points: 
  • Today, Gigantic Playground, a leading connected experience agency, proudly announces the strategic appointment of Eric Soto as Partner & Senior Vice-President for Themed-Entertainment.
  • View the full release here: https://www.businesswire.com/news/home/20240212984079/en/
    Eric Soto, Partner & Senior Vice-President of Themed-Entertainment of Gigantic Playground (Photo: Business Wire)
    Throughout his career, Eric has catered to a broad spectrum of clients across the United States, leaving a transformative impact in sectors spanning hospitality, web, commerce, and healthcare.
  • Sharing his excitement about the new role, Eric stated, "Joining Gigantic Playground as a Partner & Senior Vice-President for Themed-Entertainment marks an exhilarating new chapter in my career.
  • Eric Soto's inclusion in the leadership of Gigantic Playground is a testament to the agency's commitment to excellence and innovation.

Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference

Retrieved on: 
Monday, February 12, 2024
Digital health, Surgery, Regenerative medicine, Medtech, Conference

CANTON, Mass., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that management will participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference, which is being held at the Cliff Lodge in Snowbird, UT from February 13th-14th.

Key Points: 
  • CANTON, Mass., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that management will participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference, which is being held at the Cliff Lodge in Snowbird, UT from February 13th-14th.
  • Management will participate in 1x1 meetings on Wednesday, February 14th.
  • There will be no formal presentation.

Aptar Signs Enterprise Agreement with Biogen to Operate and Develop Digital Health Solutions

Retrieved on: 
Friday, February 9, 2024
General Health, Manufacturing, Health, Pharmaceutical, Packaging, ATR, Lupus, AptarGroup, Digital health, Neurology, Fatigue, Multimedia, BIIB, Immunology, Patient, Neuroscience, Multiple sclerosis

Aptar Digital Health, part of AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has entered into an enterprise agreement with Biogen Inc. (Nasdaq: BIIB) to operate and develop digital health solutions for neurological and rare diseases.

Key Points: 
  • Aptar Digital Health, part of AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has entered into an enterprise agreement with Biogen Inc. (Nasdaq: BIIB) to operate and develop digital health solutions for neurological and rare diseases.
  • As part of the agreement, Biogen will transfer ownership of select digital health solutions to Aptar Digital Health (Aptar).
  • In addition to these solutions, Biogen and Aptar will further collaborate to potentially develop and bring to market new digital health solutions for the management of spinal muscular amyotrophy, Friedreich’s ataxia and lupus in selected countries.
  • “We are excited to leverage our end-to-end capabilities to support Biogen and enable patients and their care teams to benefit from advanced digital solutions for better disease management,” said Pierre Leurent, President, Aptar Digital Health.

Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Retrieved on: 
Friday, February 9, 2024
Digital health, Conference

LONDON and SALT LAKE CITY, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) (the “Company”) today announced that the Company will be participating in the upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which will take place February 13-14, 2024 in Snowbird, Utah.

Key Points: 
  • LONDON and SALT LAKE CITY, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) (the “Company”) today announced that the Company will be participating in the upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which will take place February 13-14, 2024 in Snowbird, Utah.
  • Given the format of this event, no formal company presentation is expected.
  • Management will be participating in one-on-one meetings with investors during the event and meetings can be requested through BTIG.

Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference

Retrieved on: 
Thursday, February 8, 2024
Digital health, Conference, Snowbird, Medtech

MARLBOROUGH, Mass., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the fourth quarter and full year of 2023 after the market close on March 4th, 2024.

Key Points: 
  • MARLBOROUGH, Mass., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the fourth quarter and full year of 2023 after the market close on March 4th, 2024.
  • Company management will host a conference call to discuss financial results at 5:00 p.m.
  • A live and archived webcast of the event will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/ .
  • Akoya will also be participating in the upcoming BTIG at Snowbird: MedTech, Digital Health, Life Science & Diagnostic Tools Conference taking place on February 13-14, 2024.

Care2U Named to the New York Digital Health 100 by Digital Health New York (DHNY)

Retrieved on: 
Thursday, February 8, 2024
Digital health, Fungal infection, Physician, Digital, Risk, House call, Health

NEW YORK, Feb. 8, 2024 /PRNewswire/ -- Care2U today announced that it has been named to the 2024 New York Digital Health 100 (DH100), a recognition that highlights the most exciting and innovative startups in New York. Digital Health New York (DHNY) publishes the annual list in conjunction with the New York Healthcare Innovation Report which takes an in-depth look at the investment trends, opportunities and challenges in the digital health sector.

Key Points: 
  • NEW YORK, Feb. 8, 2024 /PRNewswire/ -- Care2U today announced that it has been named to the 2024 New York Digital Health 100 (DH100), a recognition that highlights the most exciting and innovative startups in New York.
  • Digital Health New York (DHNY) publishes the annual list in conjunction with the New York Healthcare Innovation Report which takes an in-depth look at the investment trends, opportunities and challenges in the digital health sector.
  • "It is truly an honor to be recognized as one of the most innovative healthcare start-up companies in New York, said Lon Hecht, Chief Growth Officer of Care2U.
  • "2024 marks the fifth year of the New York Digital Health 100 and in that time, the digital health ecosystem in New York has significantly grown and evolved," said Bunny Ellerin, co-founder and CEO, DHNY.

H1 Honored With Spot On the New York Digital Health 100 For Third Straight Year

Retrieved on: 
Thursday, February 8, 2024
MJFF, Digital health, Digital, Clinical trial, Research, Pharmaceutical industry

Digital Health New York (DHNY) publishes the annual list in conjunction with the New York Healthcare Innovation Report , which takes an in-depth look at the investment trends, opportunities, and challenges in the digital health sector.

Key Points: 
  • Digital Health New York (DHNY) publishes the annual list in conjunction with the New York Healthcare Innovation Report , which takes an in-depth look at the investment trends, opportunities, and challenges in the digital health sector.
  • This is the third consecutive year that H1 has received this honor.
  • “It’s an honor to be recognized by DHNY as a top digital health company for the third year in a row,” said Ariel Katz , co-founder and CEO at H1.
  • Our team is grateful to be recognized for these efforts.”
    “2024 marks the fifth year of the New York Digital Health 100, and in that time, the digital health ecosystem in New York has significantly grown and evolved,” said Bunny Ellerin, co-founder and CEO of DHNY.

Capital Rx Named to the 2024 New York Digital Health 100

Retrieved on: 
Thursday, February 8, 2024
Digital health, FC, Medicare, PBA, Digital, Emerge Commerce, PBM, Entrepreneurship, Cryptocurrency

NEW YORK, Feb. 8, 2024 /PRNewswire/ -- Capital Rx , the full-service pharmacy benefit manager (PBM) and pharmacy benefit administrator (PBA) advancing our nation's healthcare infrastructure to improve drug price visibility and patient outcomes, has been named to the 2024 New York Digital Health 100 (DH100) again.

Key Points: 
  • NEW YORK, Feb. 8, 2024 /PRNewswire/ -- Capital Rx , the full-service pharmacy benefit manager (PBM) and pharmacy benefit administrator (PBA) advancing our nation's healthcare infrastructure to improve drug price visibility and patient outcomes, has been named to the 2024 New York Digital Health 100 (DH100) again.
  • This recognition highlights the most exciting and innovative digital health companies in New York.
  • Digital Health New York (DHNY) publishes the annual list along with the New York Healthcare Innovation Report, which takes an in-depth look at the investment trends, opportunities, and challenges in the digital health sector.
  • "2024 marks the fifth year of the New York Digital Health 100, and in that time, the digital health ecosystem in New York has significantly grown and evolved," said Bunny Ellerin, Co-Founder and CEO of DHNY.

TailorMed Named to 2024 New York Digital Health 100

Retrieved on: 
Wednesday, February 7, 2024
Software, Managed Care, Professional Services, Data Management, Technology, Hospitals, Health Technology, Health Insurance, Insurance, Practice Management, Finance, Health, Digital health, Patient, Digital, Entrepreneurship, Pharmacy, Hospital, Cryptocurrency

For the second consecutive year, TailorMed, a leading technology company offering the nation’s largest network of patients, providers, pharmacies, and life science companies dedicated to tackling healthcare affordability, today announced that it has been named to the New York Digital Health 100 (DH100).

Key Points: 
  • For the second consecutive year, TailorMed, a leading technology company offering the nation’s largest network of patients, providers, pharmacies, and life science companies dedicated to tackling healthcare affordability, today announced that it has been named to the New York Digital Health 100 (DH100).
  • The DH100 list recognizes the most exciting and innovative startups in the New York region.
  • Digital Health New York (DHNY) publishes the annual list as part of the New York Healthcare Innovation Report , a comprehensive analysis that takes an in-depth look at the investment trends, opportunities, and challenges in the digital health sector.
  • “This further validates our efforts to remove barriers to care and holistically address our nation’s affordability crisis—for patients and healthcare organizations alike.”
    “2024 marks the fifth year of the New York Digital Health 100 and in that time, the digital health ecosystem in New York has significantly grown and evolved,” said Bunny Ellerin, Co-Founder and CEO, DHNY.